Europe Drugs for the Treatment of Asthma Market Report to 2021

November 2016 | 102 pages | ID: EC393378E6AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for the Treatment of Asthma

Revenue, means the sales value of Drugs for the Treatment of Asthma

This report studies sales (consumption) of Drugs for the Treatment of Asthma in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group
• BAX
• Taishō Seiyaku Kabushiki-gaisha

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for the Treatment of Asthma in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Beta2 Adrenergic Receptor Agonist
• M Cholinergic Receptor Antagonist
• Drugs that Affect Leukotrienes
• Glucocorticoid Drugs
• Phosphodiesterase Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Drugs for the Treatment of Asthma in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

1 DRUGS FOR THE TREATMENT OF ASTHMA OVERVIEW

1.1 Product Overview and Scope of Drugs for the Treatment of Asthma
1.2 Classification of Drugs for the Treatment of Asthma
  1.2.1 Beta2 Adrenergic Receptor Agonist
  1.2.2 M Cholinergic Receptor Antagonist
  1.2.3 Drugs that Affect Leukotrienes
  1.2.4 Glucocorticoid Drugs
  1.2.5 Phosphodiesterase Inhibitors
1.3 Applications of Drugs for the Treatment of Asthma
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Drugs for the Treatment of Asthma Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Drugs for the Treatment of Asthma (2011-2021)
  1.5.1 Europe Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  1.5.3 Europe Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)

2 EUROPE DRUGS FOR THE TREATMENT OF ASTHMA BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Drugs for the Treatment of Asthma Market Competition by Manufacturers
  2.1.1 Europe Drugs for the Treatment of Asthma Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Drugs for the Treatment of Asthma Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Drugs for the Treatment of Asthma (Volume and Value) by Type
  2.2.1 Europe Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)
2.3 Europe Drugs for the Treatment of Asthma (Volume and Value) by Regions
  2.3.1 Europe Drugs for the Treatment of Asthma Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Drugs for the Treatment of Asthma Revenue and Market Share by Regions (2011-2021)
2.4 Europe Drugs for the Treatment of Asthma (Volume) by Application

3 GERMANY DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  3.1.1 Germany Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  3.1.2 Germany Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
3.2 Germany Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
3.3 Germany Drugs for the Treatment of Asthma Sales and Market Share by Type
3.4 Germany Drugs for the Treatment of Asthma Sales and Market Share by Applications

4 UK DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

4.1 UK Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  4.1.1 UK Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  4.1.2 UK Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  4.1.3 UK Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
4.2 UK Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
4.3 UK Drugs for the Treatment of Asthma Sales and Market Share by Type
4.4 UK Drugs for the Treatment of Asthma Sales and Market Share by Applications

5 FRANCE DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

5.1 France Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  5.1.1 France Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  5.1.2 France Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  5.1.3 France Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
5.2 France Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
5.3 France Drugs for the Treatment of Asthma Sales and Market Share by Type
5.4 France Drugs for the Treatment of Asthma Sales and Market Share by Applications

6 ITALY DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  6.1.1 Italy Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  6.1.2 Italy Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
6.2 Italy Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
6.3 Italy Drugs for the Treatment of Asthma Sales and Market Share by Type
6.4 Italy Drugs for the Treatment of Asthma Sales and Market Share by Applications

7 RUSSIA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  7.1.1 Russia Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  7.1.2 Russia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
7.2 Russia Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
7.3 Russia Drugs for the Treatment of Asthma Sales and Market Share by Type
7.4 Russia Drugs for the Treatment of Asthma Sales and Market Share by Applications

8 SPAIN DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  8.1.1 Spain Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  8.1.2 Spain Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
8.2 Spain Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
8.3 Spain Drugs for the Treatment of Asthma Sales and Market Share by Type
8.4 Spain Drugs for the Treatment of Asthma Sales and Market Share by Applications

9 EUROPE DRUGS FOR THE TREATMENT OF ASTHMA MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Novartis (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Roche (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Sanofi (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
9.10 Abbvie
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbvie (2015 and 2016)
9.11 AMGen
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of AMGen (2015 and 2016)
9.12 Teva Pharmaceutical Industries Ltd.
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
9.13 Bayer AG
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Bayer AG (2015 and 2016)
9.14 Bristol-Myers Squibb
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
9.15 Astellas Pharma
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
9.16 Daiichi Sankyo
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
9.17 Abbott Laboratories
  9.17.1 Company Basic Information,Manufacturing Base and Competitors
  9.17.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.17.2.1 Type I
    9.17.2.2 Type II
  9.17.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
9.18 Yangtze River Pharmaceutical Group
  9.18.1 Company Basic Information,Manufacturing Base and Competitors
  9.18.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.18.2.1 Type I
    9.18.2.2 Type II
  9.18.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
9.19 BAX
  9.19.1 Company Basic Information,Manufacturing Base and Competitors
  9.19.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.19.2.1 Type I
    9.19.2.2 Type II
  9.19.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of BAX (2015 and 2016)
9.20 Taishō Seiyaku Kabushiki-gaisha
  9.20.1 Company Basic Information,Manufacturing Base and Competitors
  9.20.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.20.2.1 Type I
    9.20.2.2 Type II
  9.20.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)

10 DRUGS FOR THE TREATMENT OF ASTHMA TECHNOLOGY AND DEVELOPMENT TREND

10.1 Drugs for the Treatment of Asthma Technology Analysis
10.2 Drugs for the Treatment of Asthma Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for the Treatment of Asthma
Table Classification of Drugs for the Treatment of Asthma
Figure Europe Sales Market Share of Drugs for the Treatment of Asthma by Types in 2015
Figure Beta2 Adrenergic Receptor Agonist Picture
Figure M Cholinergic Receptor Antagonist Picture
Figure Drugs that Affect Leukotrienes Picture
Figure Glucocorticoid Drugs Picture
Figure Phosphodiesterase Inhibitors Picture
Table Applications of Drugs for the Treatment of Asthma
Figure Europe Sales Market Share of Drugs for the Treatment of Asthma by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure Germany Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure France Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure UK Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Italy Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Spain Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Russia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales of Key Manufacturers (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Figure 2016 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Table Europe Drugs for the Treatment of Asthma Revenue by Manufacturers (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table 2016 Europe Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table Europe Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Sales Growth Rate by Type (2011-2021)
Table Europe Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)
Table Europe Drugs for the Treatment of Asthma Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Revenue Growth Rate by Type (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales and Market Share by Regions (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales Share by Regions (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Regions (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Sales Growth Rate by Regions (2011-2021)
Table Europe Drugs for the Treatment of Asthma Revenue and Market Share by Regions (2011-2021)
Table Europe Drugs for the Treatment of Asthma Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Drugs for the Treatment of Asthma by Regions (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Revenue Growth Rate by Regions (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales and Market Share by Application (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Application (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Sales Growth Rate by Application (2011-2021)
Figure Germany Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Germany Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Germany Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Germany Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Germany Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Germany Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Germany Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Germany Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Germany Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure UK Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure UK Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure UK Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table UK Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table UK Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table UK Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table UK Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table UK Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table UK Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure France Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure France Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure France Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table France Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table France Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table France Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table France Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table France Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table France Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Italy Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Italy Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Italy Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Italy Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Italy Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Italy Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Italy Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Italy Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Italy Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Russia Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Russia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Russia Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Russia Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Russia Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Russia Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Russia Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Russia Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Russia Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Spain Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Spain Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Spain Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Spain Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Spain Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Spain Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Spain Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Spain Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Spain Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbvie (2015 and 2016)
...